US Bancorp’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $507M | Sell |
2,328,944
-29,268
| -1% | -$6.49M | 0.61% | 38 |
|
|
2025
Q4 | $539M | Sell |
2,358,212
-41,982
| -2% | -$9.56M | 0.63% | 33 |
|
|
2025
Q3 | $556M | Sell |
2,400,194
-30,755
| -1% | -$6.26M | 0.66% | 33 |
|
|
2025
Q2 | $451M | Sell |
2,430,949
-39,226
| -2% | -$7.29M | 0.57% | 35 |
|
|
2025
Q1 | $518M | Sell |
2,470,175
-38,590
| -2% | -$7.5M | 0.69% | 33 |
|
|
2024
Q4 | $446M | Sell |
2,508,765
-24,245
| -1% | -$4.46M | 0.58% | 36 |
|
|
2024
Q3 | $500M | Sell |
2,533,010
-21,719
| -0.9% | -$4.05M | 0.64% | 32 |
|
|
2024
Q2 | $438M | Sell |
2,554,729
-39,252
| -2% | -$6.5M | 0.6% | 33 |
|
|
2024
Q1 | $472M | Sell |
2,593,981
-12,099
| -0.5% | -$2.09M | 0.66% | 30 |
|
|
2023
Q4 | $404M | Sell |
2,606,080
-13,174
| -0.5% | -$1.92M | 0.6% | 33 |
|
|
2023
Q3 | $390M | Buy |
2,619,254
+34,364
| +1% | +$5.04M | 0.64% | 32 |
|
|
2023
Q2 | $348M | Sell |
2,584,890
-27,106
| -1% | -$3.97M | 0.56% | 36 |
|
|
2023
Q1 | $416M | Buy |
2,611,996
+13,258
| +0.5% | +$2.03M | 0.7% | 31 |
|
|
2022
Q4 | $420M | Buy |
2,598,738
+46,786
| +2% | +$7.17M | 0.74% | 33 |
|
|
2022
Q3 | $342M | Sell |
2,551,952
-33,801
| -1% | -$4.85M | 0.71% | 32 |
|
|
2022
Q2 | $396M | Sell |
2,585,753
-2,678
| -0.1% | -$409K | 0.77% | 28 |
|
|
2022
Q1 | $420M | Sell |
2,588,431
-26,588
| -1% | -$3.86M | 0.7% | 29 |
|
|
2021
Q4 | $354M | Buy |
2,615,019
+4,227
| +0.2% | +$499K | 0.56% | 37 |
|
|
2021
Q3 | $282M | Buy |
2,610,792
+13,670
| +0.5% | +$1.56M | 0.53% | 43 |
|
|
2021
Q2 | $293M | Sell |
2,597,122
-60,814
| -2% | -$6.85M | 0.55% | 43 |
|
|
2021
Q1 | $288M | Sell |
2,657,936
-33,871
| -1% | -$3.62M | 0.58% | 39 |
|
|
2020
Q4 | $288M | Sell |
2,691,807
-18,057
| -0.7% | -$1.74M | 0.62% | 36 |
|
|
2020
Q3 | $237M | Sell |
2,709,864
-10,132
| -0.4% | -$954K | 0.58% | 40 |
|
|
2020
Q2 | $267M | Sell |
2,719,996
-131,752
| -5% | -$11.6M | 0.7% | 33 |
|
|
2020
Q1 | $217M | Sell |
2,851,748
-26,306
| -0.9% | -$2.24M | 0.68% | 32 |
|
|
2019
Q4 | $255M | Sell |
2,878,054
-204,445
| -7% | -$17M | 0.65% | 35 |
|
|
2019
Q3 | $233M | Sell |
3,082,499
-108,824
| -3% | -$7.46M | 0.64% | 38 |
|
|
2019
Q2 | $232M | Buy |
3,191,323
+53,921
| +2% | +$4.24M | 0.65% | 38 |
|
|
2019
Q1 | $253M | Sell |
3,137,402
-73,447
| -2% | -$6.01M | 0.73% | 30 |
|
|
2018
Q4 | $296M | Buy |
3,210,849
+376,886
| +13% | +$33.1M | 0.96% | 20 |
|
|
2018
Q3 | $268M | Buy |
2,833,963
+15,349
| +0.5% | +$1.46M | 0.78% | 25 |
|
|
2018
Q2 | $261M | Sell |
2,818,614
-36,031
| -1% | -$3.52M | 0.8% | 26 |
|
|
2018
Q1 | $270M | Sell |
2,854,645
-67,631
| -2% | -$7.43M | 0.83% | 23 |
|
|
2017
Q4 | $283M | Sell |
2,922,276
-1,469
| -0.1% | -$138K | 0.86% | 22 |
|
|
2017
Q3 | $260M | Sell |
2,923,745
-14,941
| -0.5% | -$1.14M | 0.83% | 22 |
|
|
2017
Q2 | $213M | Sell |
2,938,686
-8,875
| -0.3% | -$597K | 0.71% | 24 |
|
|
2017
Q1 | $192M | Buy |
2,947,561
+9,289
| +0.3% | +$584K | 0.66% | 30 |
|
|
2016
Q4 | $184M | Sell |
2,938,272
-25,385
| -0.9% | -$1.55M | 0.66% | 29 |
|
|
2016
Q3 | $187M | Buy |
2,963,657
+91,241
| +3% | +$5.91M | 0.69% | 29 |
|
|
2016
Q2 | $178M | Buy |
2,872,416
+57,490
| +2% | +$3.5M | 0.68% | 31 |
|
|
2016
Q1 | $161M | Sell |
2,814,926
-24,856
| -0.9% | -$1.39M | 0.63% | 33 |
|
|
2015
Q4 | $168M | Sell |
2,839,782
-62,235
| -2% | -$3.58M | 0.68% | 28 |
|
|
2015
Q3 | $158M | Sell |
2,902,017
-93,624
| -3% | -$6.09M | 0.66% | 29 |
|
|
2015
Q2 | $201M | Buy |
2,995,641
+15,781
| +0.5% | +$1.03M | 0.78% | 21 |
|
|
2015
Q1 | $174M | Buy |
2,979,860
+114,713
| +4% | +$6.93M | 0.67% | 31 |
|
|
2014
Q4 | $187M | Sell |
2,865,147
-10,622
| -0.4% | -$670K | 0.72% | 23 |
|
|
2014
Q3 | $166M | Buy |
2,875,769
+20,228
| +0.7% | +$1.12M | 0.67% | 29 |
|
|
2014
Q2 | $161M | Sell |
2,855,541
-100,247
| -3% | -$5.26M | 0.64% | 35 |
|
|
2014
Q1 | $152M | Sell |
2,955,788
-86,556
| -3% | -$4.37M | 0.62% | 38 |
|
|
2013
Q4 | $161M | Sell |
3,042,344
-94,112
| -3% | -$4.63M | 0.65% | 34 |
|
|
2013
Q3 | $140M | Sell |
3,136,456
-40,890
| -1% | -$1.81M | 0.62% | 37 |
|
|
2013
Q2 | $131M | Buy |
+3,177,346
| New | +$139M | 0.6% | 41 |
|
Other funds holding ABBV
VCM
VPM
US Bancorp's ABBV Position: Q1 2026 in Review
US Bancorp reduced its AbbVie (ABBV) stake by 1.2% in Q1 2026, selling an estimated $6.49M and leaving 2,328,944 shares worth $507M. The position accounts for 0.61% of the portfolio, ranked #38.
US Bancorp first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $556M in Q3 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- US Bancorp held 2,328,944 shares of AbbVie worth $507M as of Q1 2026.
- US Bancorp sold 29,268 AbbVie shares in Q1 2026, an estimated $6.49M.
- AbbVie made up 0.61% of US Bancorp's portfolio in Q1 2026, its #38 holding.
- US Bancorp first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- US Bancorp's AbbVie position peaked at $556M in Q3 2025.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on US Bancorp's 13F filing for Q1 2026, filed 15 May 2026.